Research from Cardiff University reveals good news for patients suffering from a variety of cancers. The University’s study shows that patients who supplement their cancer treatments with a regimen of low-dose aspirin increased their survival rate by almost 20 percent. This is good news for patients as they await more effective treatments from drug manufacturers. <br /> <br />Berke Executive Search anticipates the findings will reinvigorate the interaction of commonly available drugs with cancer treatments. A pharmaceutical executive search will be necessary for companies looking to develop new cancer drugs. Berke Executive Search has over 30 years of experience matching the best healthcare and pharmaceutical talent with the right company. For more information about Berke Executive Search visit www.BerkeSearch.com or call 267-483-8951 today!
